Patients With Cancer Should Speak Up About Mental Health Struggles if They Don’t Feel Heard, Expert Says

Video

A psychiatrist advises patients with cancer to speak up about their mental health concerns during cancer treatment, as there are tools that can guide best next steps.

Patients with cancer who have mental health struggles during treatment should not wait to reach out to their health care providers, according to Dr. Wendy Baer, a psychiatrist at the Winship Cancer Institute at Emory University in Atlanta.

Baer explained that clinicians have tools that they should be utilizing to measure levels of distress that patients are going through, such as the National Comprehensive Cancer Network’s Distress Thermometer, which measures physical concerns — such as pain, sleep issues and changing in eating habits — as well as emotional, social, practical and spiritual concerns.

Once clinicians better understand the feelings that patients are experiencing, they may be able to recommend seeing a therapist, joining a support group or another method to help manage the distress.

READ MORE: Addressing Psychosocial Needs in Cancer Care Has Improved Over Past 20 Years, But More Work Still Needed

Transcription:

I think if people are getting treated in a place where they don't feel heard, or that some of their emotional concerns aren't getting addressed, it's worth bringing up. It's worth talking about with your (health care) team and see if you start a conversation if they can go anywhere.

There are guidelines for managing emotional states in cancer, and they're put out by the National Comprehensive Cancer Network. The instrument we use to measure emotional well-being and cancer is called the Distress Thermometer. And so that is actually recommended to be used in cancer centers. So, if we think about what the professional organizations in cancer are doing, they're actually saying we should attend to people's mental well-being while they're going through cancer.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Related Videos
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.